Podcasts about Breast Cancer Care

In the wake of recent key data about ESR1-mutated metastatic breast cancer, treatment decisions have become more complicated. “In current clinical practice, this is not a straightforward decision,” Marla Lipsyc-Sharf, MD, explains to Robert A. Figlin, MD.  

As the management of patients with ESR1-mutated metastatic breast cancer evolves, various questions have emerged in clinical practice. “It's a complex situation,” explains Hope S. Rugo, MD, division chief of breast medical oncology and the Women's Cancers Program director at the City of Hope Comprehensive Cancer Center in Duarte, California. She discusses how recent advances have changed treatment decisions with Robert A. Figlin, MD, the Steven Spielberg Family Chair in Hematology-Oncology at Cedars-Sinai Cancer in Los Angeles. “I think it's important to keep in mind that today we just have single-agent oral SERDs, and people like to give combinations,” Dr. Rugo notes. But what combinations to give and when remains unclear. “I think how we're going to decide is that we're going to wait and see what's approved and then look at patients to try and figure out what to do,” she offers.  

Send us Fan MailPaper Discussed in this Episode: How artificial intelligence applied to digital pathology could guide treatment personalization in breast cancer. T. Ruelle, T. Grinda, L. Del Mastro, M. Lacroix-Triki, B. Pistilli & G. Gessain. ESMO Real World Data and Digital Oncology 2026.Episode Summary: In this journal club episode, we step into the reality of computational pathology and explore how artificial intelligence is fundamentally transforming breast cancer diagnostics. We examine a comprehensive review detailing how AI not only assists overburdened healthcare systems but also unlocks invisible genomic data straight from a standard $5 hematoxylin-eosin (H&E) glass slide. What happens when a machine can predict complex DNA mutations just by evaluating the structural architecture of cells?In This Episode, We Cover:• The Diagnostic Bottleneck: Understanding the critical worldwide shortage of pathologists colliding with a projected 3.2 million global breast cancer diagnoses by 2050, and why the system is under unprecedented strain.• The Biomarker Battle: Why the human visual cortex struggles to quantify faint immunohistochemistry stains, and how AI acts as a perfect "digital colorimeter". We discuss its near-perfect concordance in assessing crucial biomarkers like Ki-67, ER, PR, PD-L1, and the newly established HER2-low status.• Seeing the Invisible (Predictive AI): How deep learning transcends visual diagnostics to predict treatment outcomes, such as a patient's response to neoadjuvant chemotherapy. We also discuss AI's ability to infer Homologous Recombination Deficiency (HRD) and BRCA1/2 mutations by identifying macroscopic footprints like laminated fibrosis.• Decoding Genomic Assays: The potential to replace expensive, tissue-consuming genomic tests like Oncotype DX with AI models (such as Orpheus) that predict recurrence risk straight from digitized slides, achieving accuracy that rivals the tests themselves.• Roadblocks to Reality: The major clinical friction preventing global rollout. We discuss the steep infrastructure costs of whole-slide scanners, the danger of AI bias across diverse hospital datasets, and the ethical "black box" problem requiring the evolution of transparent, agent-based AI.Key Takeaway: Computational pathology is moving far beyond basic diagnostic assistance. By successfully reading the structural language of biology, AI proves it can extract costly, invisible molecular data from standard biopsies, fundamentally changing the economics and accessibility of global personalized healthcareSupport the showGet the "Digital Pathology 101" FREE E-book and join us!

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/AUX865. CME/MOC/CC/AAPA/IPCE credit will be available until April 5, 2027.Lighting the Path in Early Breast Cancer Care: Uniting Evidence, Expertise, and Multidisciplinary Action In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from AstraZeneca and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/AUX865. CME/MOC/CC/AAPA/IPCE credit will be available until April 5, 2027.Lighting the Path in Early Breast Cancer Care: Uniting Evidence, Expertise, and Multidisciplinary Action In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from AstraZeneca and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/AUX865. CME/MOC/CC/AAPA/IPCE credit will be available until April 5, 2027.Lighting the Path in Early Breast Cancer Care: Uniting Evidence, Expertise, and Multidisciplinary Action In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from AstraZeneca and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/AUX865. CME/MOC/CC/AAPA/IPCE credit will be available until April 5, 2027.Lighting the Path in Early Breast Cancer Care: Uniting Evidence, Expertise, and Multidisciplinary Action In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from AstraZeneca and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/AUX865. CME/MOC/CC/AAPA/IPCE credit will be available until April 5, 2027.Lighting the Path in Early Breast Cancer Care: Uniting Evidence, Expertise, and Multidisciplinary Action In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from AstraZeneca and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/AUX865. CME/MOC/CC/AAPA/IPCE credit will be available until April 5, 2027.Lighting the Path in Early Breast Cancer Care: Uniting Evidence, Expertise, and Multidisciplinary Action In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from AstraZeneca and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

How are oncologists currently approaching the care of patients with ESR1-mutated advanced breast cancer in practice? Erin Frances Cobain, MD, associate professor at the University of Michigan Rogel Cancer Center in Ann Arbor, speaks with Wassim Mchayleh, MD, MBA, the clinical program director of the breast cancer program at AdventHealth Cancer Institute and associate professor of medicine at the University of Central Florida in Orlando, about how to best use oral selective estrogen receptor degraders. “And the big question is ‘Can we use SERDs in combination, or are SERDs effective in patients without an ESR1 mutation?' Can we go outside the current approved guidelines? And I think that's the biggest question that everyone is asking today,” notes Dr. Mchayleh.

AI-powered support tools are moving fast in health care — and breast cancer is no exception. In this special episode, we look at how AI companions and chat tools might expand access to support, while also raising serious concerns about accuracy, bias, privacy and inequity. Host Adam Walker is joined by breast cancer survivor Ellyn Winters-Robinson to discuss what it means to design AI with lived experience, cultural responsiveness and patient safety at the center. They explore where AI can help (navigation of information, emotional reassurance, questions to bring to appointments) and where human expertise must remain non-negotiable.

In this highly emotive episode of Women & Wellbeing, actor, producer and breast cancer campaigner Victoria Ekanoye is joined by her mum, Candy, for a deeply moving conversation about resilience, family and using personal experience to create change. As both breast cancer survivors, Victoria and Candy share their experience of navigating diagnosis, treatment and the steady steps towards recovery whilst for bolstering each other with strength and support. Together, they reflect on how their shared experience opened up important conversations around women's health, vulnerability and the power of the mother–daughter relationship during life's most difficult moments. The conversation also explores the wider disparities that exist in cancer care for Black women around the world. Victoria and Candy speak candidly about why awareness, early detection and representation matter — and why challenging silence and stigma around cancer remains an essential part of their advocacy. Victoria is currently fronting the award winning documentary Shades of Survival, which shines a light on how breast cancer is experienced and treated across different countries and cultures. Through the project, she is helping to amplify global conversations around equity in healthcare and access to life-saving support. Alongside their work with Prevent Breast Cancer, the pair are also lobbying the UK government for greater awareness and policy change — ensuring that women's voices, experiences and outcomes are better represented in cancer care. Later in the conversation we discuss Victoria's gradual return to on-screen work following treatment, including her role in the Paramount Plus smash hit 'Girl Taken', and how creativity, purpose and storytelling have been part of her healing journey alongside being a mother to her young son Theo. Together, we discuss: – Surviving breast cancer as mother and daughter – The power of family support during illness – Disparities in cancer care for Black women globally – Cultural perceptions and stigma around cancer – Advocacy, awareness and policy change – Opening up intergenerational conversations around women's health – Returning to creativity and career after illness This episode is a story of survival, love and determination — and a reminder that personal stories have the power to shift awareness, challenge systems and inspire change. For more wellbeing and lifestyle visit The Capsule at www.thecapsule.co.ukGet involved with our community and join us on Instagram & YouTube Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode of SurgOnc Today, join Dr. Ana Refinetti and Dr. Shruti Zaveri as they interview Dr. Iryna Jacinto, a recent SSO ICDE participant who is spearheading breast cancer care programming in Angola.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/WWQ865. CME/MOC/NCPD/AAPA/IPCE credit will be available until February 12, 2027.TROP2-Targeting ADCs in the Forefront: Changing Standards and Best Practices in TNBC and HR+, HER2- Breast Cancer Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Gilead Sciences, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/WWQ865. CME/MOC/NCPD/AAPA/IPCE credit will be available until February 12, 2027.TROP2-Targeting ADCs in the Forefront: Changing Standards and Best Practices in TNBC and HR+, HER2- Breast Cancer Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Gilead Sciences, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/WWQ865. CME/MOC/NCPD/AAPA/IPCE credit will be available until February 12, 2027.TROP2-Targeting ADCs in the Forefront: Changing Standards and Best Practices in TNBC and HR+, HER2- Breast Cancer Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Gilead Sciences, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/WWQ865. CME/MOC/NCPD/AAPA/IPCE credit will be available until February 12, 2027.TROP2-Targeting ADCs in the Forefront: Changing Standards and Best Practices in TNBC and HR+, HER2- Breast Cancer Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Gilead Sciences, Inc.Disclosure information is available at the beginning of the video presentation.

Asking for help is never easy. Dorothy Gibbons introduces Kathia, manager at The Rose’s southeast location. Three departments fall under Kathia’s leadership: medical records, registration, and sponsorship programs. The Rose offers care and access, removing barriers like language, cost, and transportation. Even after diagnosis, bilingual patient navigators remain with patients, helping them through paperwork and treatment. Preventive care and self-advocacy are emphasized throughout. Please consider sharing this episode, or making a donation at therose.org so more women receive breast cancer screening and care. Subscribe to Let’s Talk About Your Breasts on Apple Podcasts, Spotify, iHeart, and wherever you get your podcasts. Key Questions Answered 1. What is Kathia’s role at The Rose?2. What does 'removing barriers' mean at The Rose?3. How does the sponsorship program at The Rose work?4. Why is it hard for women to ask for help regarding their healthcare?5. What is the process for patients who may need sponsorship?6. How does Kathia personally relate to patients at The Rose?7. What support does The Rose provide for patients diagnosed with breast cancer and facing barriers?8. How does the new system at The Rose improve patient experience? Timestamped Overview 00:00 Patient-Centered Care Program 05:20 Building Relationships Before Sponsorship 08:07 Healthcare Barriers for Non-English Speakers 11:02 Support Resources for Cancer Patients 13:13 Patient Education Process Explained 18:15 Teaching Self-Advocacy to Kids 22:32 Compassionate Staff with Shared Experiences 23:13 Connection and Mission ForwardSee omnystudio.com/listener for privacy information.

CME credits: 0.25 Valid until: 30-01-2027 Claim your CME credit at https://reachmd.com/programs/cme/progress-in-breast-cancer-care-translating-sabcs-data-into-practice/48989/ This online educational activity equips clinicians with up-to-date, practice-changing insights from SABCS 2025. Experts review pivotal data across early-stage and metastatic breast cancer, including advances in HER2- and TROP2-directed ADCs, and discuss how these findings can meaningfully inform treatment selection. Participants will learn how to apply new evidence to expand therapeutic options, improve patient outcomes, and navigate emerging safety and quality of life considerations.=

North Fork Breast Health Coalition's Melanie McEvoy and Dr. Michelle Iona join Heart of The East End Gianna Volpe on WLIW-FM ahead of their free seminar, “Integrative Approaches to Breast Cancer Care,” featuring top physicians and medical professionals from MSK Sloan Kettering, New York Cancer & Blood Specialists, Northwell Health Cancer Center and Stony Brook Cancer Center at Hotel Indigo from 8:30 a.m. to 2 p.m. on Saturday, January 31Listen to the playlist on Apple MusicWatch the interview on WLIW-FM YouTube

Did you know that, while well established in the metastatic setting, second-generation antibody-drug conjugates are now moving into the early setting? Credit available for this activity expires: 12/10/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/how-are-adcs-shaping-future-early-breast-cancer-care-latest-2025a1000yca?ecd=bdc_podcast_libsyn_mscpedu

At the 2025 San Antonio Breast Cancer Symposium (SABCS), Dr. Tara Sanft, associate professor of medicine at the Yale School of Medicine and director of the Yale Survivorship Clinic, moderated a session called “Balancing Act: Hormone Replacement Therapy in Breast Cancer Care.” Listen to the episode to hear Dr. Sanft explain: the difference between systemic and local HRT why HRT decisions need to be nuanced and individualized for anyone with a history of breast cancer – there is no one-size-fits-all her advice to people with a history of breast cancer who are considering HRT

Join this program for relevant updates across the advanced and metastatic breast cancer (mBC) spectrum as presented in October 2025. Credit available for this activity expires: 12/8/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/hot-topics-berlin-2025-what-experts-say-about-future-2025a1000x8r?ecd=bdc_podcast_libsyn_mscpedu

We Rise Together: An Evening of Education, Empowerment andEleganceSponsored by “The Breast Cancer Podcast” and “Ish and SaviFoundation”In person event in Columbus, OH, USA on Nov 15 th , 2025Expert Panel 1: Advances in After Breast Cancer Care1. Breast Surgery: - Follow-Up After Breast Cancer: To Scan or Not to Scan?” Dr. Mark Cripe2. Plastic surgery: “Optimizing outcomes after reconstruction, latest advances in2025.” Dr. Nirvana Saraswat3. Medical Oncology: “The Next Chapter: Thriving, Not Just Surviving, After BreastCancer.” Dr. Shabana Dewani4.     Radiation Oncology: “Radiation Complete… Now What? Your Follow-UpRoadmap” Dr. Vijay KudithipudiSpeed Dating with the Experts: Moderator- Dr. Mark Cripe (Breast andMelanoma Surgeon)Experts:1. Dr. Shabana Dewani- Medical Oncologist2. Dr. Nirvana Saraswat- Plastic and Reconstructive Microsurgeon3. Dr. Vijay Kudithipudi- Radiation Oncologist4. Dr. Tyler Sbrocchi- Plastic and Reconstructive Surgeon5. Dr. Santosh Kale- Plastic and Reconstructive MicrosurgeonStay Connected with Dr. Deepa Halaharvi:TikTok: @breastdoctorInstagram: @drdhalaharviTBCP Instagram: @thebreastcancerpodcastWebsite: https://drdeepahalaharvi.com/YouTube: https://www.youtube.com/@deepahalaharvi5917Instagram: @thebreastcancerpodcast

In this episode of SHE MD Podcast, Dr. Lisa Newman and William P. Lauder join hosts Dr. Thaïs Aliabadi and Mary Alice Haney to discuss breast cancer management, multidisciplinary care, and leadership in health advocacy. They explore the latest clinical research, patient-centered strategies, and the role of philanthropy in advancing care. Learn how to improve breast health outcomes, understand treatment options, and engage with supportive programs. This episode delivers expert insights on bridging medical innovation with community impact, empowering listeners to take informed steps in their health and wellness journeys.Subscribe to SHE MD Podcast for expert tips on PCOS, Endometriosis, fertility, and hormonal balance. Share with friends and visit SHE MD website and Ovii for research-backed resources, holistic health strategies, and expert guidance on women's health and well-being.SponsorsPurely Elizabeth - Visit purelyelizabeth.com and use code SHEMD at checkout for 20% off. Purely Elizabeth. Taste the Obsession. Timeline - Timeline is offering10% off your order of Mitopure. Go to timeline.com/SHEMD.Cymbiotika - Go to Cymbiotika.com/Shemd for 20% off plus free shippingiRestore - For a limited time, get a HUGE discount on the iRESTORE Elite + Illumina Face Mask Bundle with code SHEMD at iRestore.comPeloton - Let yourself run, lift, sculpt, push, and go. Explore the new Peloton Cross Training Tread+ at onepeloton.comDavid's Protein - David is giving my listeners an exclusive offer – buy four cartons and get the fifth free at davidprotein.com/shemd Aura Frames - Exclusive $45-off Carver Mat at https://on.auraframes.com/SHEMD. Promo Code SHEMDWhat You'll LearnLatest advancements in breast cancer managementHow multidisciplinary care improves patient outcomesThe impact of philanthropy on breast cancer research and community supportLeadership lessons in healthcare and patient advocacyKey Timestamps00:00 Introduction with Dr. Thaïs Aliabadi and Mary Alice Haney02:36 William P. Lauder & Dr. Lisa Newman Introductions04:13 When William's mother was diagnosed with breast cancer & how the pink ribbon was created13:15 Educating women on preventative care, genetic testing & the risk assessment tool22:38 Dr. Newman's research on the disparities of breast cancer in black women37:14 The inherent bias in the medical community towards women and the perception of treatment46:04 Increased breast cancer diagnoses in younger women51:58 How to start the process on your own for preventative care58:02 Risk assessment and screening mammogram01:05:41 Supporters of the Breast Cancer Research Foundation01:09:56 Conversation about Estée Lauder01:13:13 Closing thoughts and actionable guidanceKey Takeaways (5 Items)Multidisciplinary care leads to better patient outcomes in breast oncologyPhilanthropy and advocacy enhance research and community supportLeadership and decision-making shape healthcare innovationsPatient-centered strategies empower individuals during treatmentCollaboration between medical, corporate, and community sectors drives changeDr. Lisa Newman is a surgical oncologist specializing in breast cancer management. She is Chief of the Section of Breast Surgery at NewYork-Presbyterian/Weill Cornell Medical Center and leads multidisciplinary breast oncology programs providing compassionate, cutting-edge care. More at Weill Cornell.William P. Lauder is Chair, Board of Directors, The Estée Lauder Companies, Co-Chair of the Breast Cancer Research Foundation, and a guest lecturer at the Wharton School. As a third-generation Lauder, he champions philanthropy, leadership, and advancing breast cancer research. More at LinkedIn.Links https://www.linkedin.com/in/william-lauder/ https://weillcornell.org/lisa-newman Patient Support Programs – https://www.shemdpodcast.com/resourcesBreast Cancer Research Foundation – https://www.bcrf.orgSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

ADCs as first-line treatment? ESR1 monitoring before progression? Local therapy for CNS disease? Experts tackle today's toughest decisions. Credit available for this activity expires: 11/14/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/charting-course-metastatic-breast-cancer-care-optimizing-2025a1000v4s?ecd=bdc_podcast_libsyn_mscpedu

Please visit answersincme.com/XCG860 to participate, download slides and supporting materials, complete the post test, and obtain credit. This educational activity brings together leading experts in ophthalmology and oncology to explore clinical strategies for managing ocular adverse events associated with a novel class of therapies for advanced breast cancer: the oral selective estrogen receptor degraders (SERDs). Faculty will share key insights and practical guidance on identifying and managing common ocular side effects—particularly photopsia and dry eye—with the goal of enhancing patient care and improving quality of life for individuals navigating survivorship with advanced breast cancer. Upon completion of this activity, participants should be better able to: Recognize the implications of using oral SERDs in HR-positive, HER2-negative breast cancer for ophthalmic practice; Describe the ocular toxicities associated with oral SERDs used in breast cancer treatment; and Apply multidisciplinary strategies to facilitate the detection and management of ocular toxicities in patients receiving oral SERDs.

This life-saving conversation is for anyone who has—or loves someone who has—breasts. It's what to look for, what to ask, what screenings you *actually need* (not just what is offered), and every decision point you have (even if it's not offered to you) if you are facing surgery.   This Breast Cancer Awareness Month, Glennon, Abby, and Amanda empower us with the most vital tool we have: information. Amanda reflects on how self-advocacy led her to her own breast cancer diagnosis—and we hear from the pod squad about how Amanda's transparency helped save their lives. Then, we're joined by Amanda's renowned doctor, Dr. Lucy M. De La Cruz, who reminds us that every patient has agency—and shares how to choose the treatment path that's right for you. And special shout out and thanks to Pod Squader Lori Mihalich-Levin (@mindfulreturn) for being such a special part of this story! If you or someone you love has been diagnosed with breast cancer, please save this episode or send it to the people you love. We love you.  For more on Amanda's Breast Cancer journey:  - Amanda's Diagnosis and What's Next (Part 1) - Amanda's Diagnosis and What's Next (Part 2) - Amanda Returns Post Surgery: Here's What She Wants You to Know  - What Amanda's Learned About Life, Love & Community (Post Surgery Pt 2)  - Early Detection, Mammograms & Breast Cancer Care with Dr. Rachel Brem  - Expert Advice on Genetic Testing, Cancer Prevention & Care Disparities with Dr. Rachel Brem  About Dr. De La Cruz:  Dr. Lucy M. De La Cruz is an internationally recognized breast surgical oncologist and the youngest Latina Chief of Breast Surgery in an academic institution in the United States. She serves as Chief of Breast Surgery and Director of the Betty Lou Ourisman Breast Health Center at MedStar Georgetown University Hospital, a nationally ranked center of excellence in breast cancer care. Dr. De La Cruz specializes in nipple-sparing mastectomies with structural preservation and resensation, with a focus on highly specialized single-stage implant reconstruction. Patients describe her not only as a world-class surgeon, but as a fierce advocate and mentor—especially for women navigating the complexities of diagnosis, treatment, and survivorship. 

Join Lance Burrell for an insightful conversation with Dr. Gary Ulaner, as they discuss the role of nuclear medicine in breast cancer treatment and lesser-known breast cancer types.

Dr. Magdalena Lombardi Plasilova discusses the groundbreaking impact of artificial intelligence (AI) in breast cancer diagnosis and treatments. She highlights how AI assists doctors in many ways, including interpreting mammograms and identifying suspicious lesions. She reviews issues concerning bias in AI algorithms and datasets when used in healthcare settings. She gives an overview of the potential of AI in creating personalized and efficient treatment plans for breast cancer patients; ultimately leading to earlier diagnosis and improved outcomes.To schedule with Dr. Magdalena Lombardi Plasilova, please visit: https://weillcornell.org/plasilova-md

October is Breast Cancer Awareness Month so we're doing our part to increase awareness about breast cancer and the importance of screening, both self and diagnostic, and learning about how treatments and screenings have evolved since 1985 when Breast Cancer Awareness Month was initiated. According to the National Breast Cancer Foundation 1 in 8 women in the United States will be diagnosed with breast cancer in their lifetime. We get a snapshot of the state of screening and treatment, and risk factors to consider — and we learn about Partners for Breast Cancer Care, a nonprofit that funds breast screening, diagnostic testing, and treatment for uninsured patients in Lee, Collier, Charlotte, Hendry and Glades counties.

Breast cancer care has come a long way – and the progress is inspiring. WakeMed breast oncologist Dr. Pallavi Kopparthy shares how treatments are now more precise, recovery is gentler and early detection continues to save lives. Learn more about breakthroughs making treatment more effective and helping women thrive after breast cancer.  Learn more about Pallavi Kopparthy, MD

Tolaney focuses on advancing breast cancer treatment through innovative clinical research. She has been instrumental in developing novel therapies and leading key clinical trials, particularly for early-stage HER2-positive breast cancer.     Timestamps   00:09 – Introduction  01:12 – What is HER2-positive breast cancer?  03:00 – Key trials Tolaney has led  07:16 – Antibody-drug conjugates  12:00 - Breast Oncology Guidelines  14:51 – Treatment optimisation   18:27 – Equity in healthcare  21:10 – Mentoring the next generation of oncologists  22:52 – Tolaney's wishes for healthcare 

In this inspiring episode of "The Brand Called You," host Ashutosh Garg sits down with Professor Kris Chatamra, Director of the Queen Sirikit Centre for Breast Cancer (QSCBC) in Bangkok, Thailand. Prof. Chatamra shares his remarkable journey from the UK back to Thailand, pioneering multidisciplinary, patient-centered cancer care, and establishing groundbreaking early detection and awareness programs in breast cancer across Southeast Asia.Discover how royal patronage, international experience, and relentless dedication shaped the QSCBC into a sanctuary for women from around the world, and learn about the emotional resilience required to work in oncology. Prof. Chatamra also discusses the innovative tumor bank, genome profiling initiatives, and the future of breast cancer treatment.Whether you're interested in medicine, women's health, public health advocacy, or personal inspiration, this conversation delivers heartfelt insights into leadership, global health challenges, and a vision of compassionate care.

In this episode of Onc Now, host Jonathan Sackier is joined by Simon Lord, Associate Professor in Experimental Cancer Therapeutics, University of Oxford, UK, to discuss translating scientific breakthroughs into real-world treatments. With deep expertise in precision medicine and a passion for innovation in oncology, Lord brings a unique perspective on how the future of cancer therapy is being shaped today.      Timestamps  01:04 – Quickfire question  11:26 – Metabolic imaging  15:26 – Insulin resistance  18:04 – Patient-specific biology  20:35 – Tamoxifen risks  21:57 – Metabolic interventions  24:46 – Lifestyle changes  27:04 – Clinical trials  00:00 – Wishes for healthcare 

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Hope S. Rugo, MD, FASCO Not only is PI3Kα the most common mutation seen in patients with HR+/HER2- advanced breast cancer, but it's also associated with endocrine therapy resistance and more aggressive cancer growth. Given its prevalence and impact on outcomes, it's important to know how and when to test for this mutation and how emerging targeted therapies might change our approach in clinical practice. Joining Dr. Charles Turck to share her insights on PI3Kα testing and targeted therapies for HR+/HER2- advanced breast cancer is Dr. Hope Rugo, Director of the Women's Cancers Program, Division Chief of Breast Medical Oncology and Professor of the Department of Medical Oncology and Therapeutics Research at City of Hope Comprehensive Cancer Center.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Hope S. Rugo, MD, FASCO Not only is PI3Kα the most common mutation seen in patients with HR+/HER2- advanced breast cancer, but it's also associated with endocrine therapy resistance and more aggressive cancer growth. Given its prevalence and impact on outcomes, it's important to know how and when to test for this mutation and how emerging targeted therapies might change our approach in clinical practice. Joining Dr. Charles Turck to share her insights on PI3Kα testing and targeted therapies for HR+/HER2- advanced breast cancer is Dr. Hope Rugo, Director of the Women's Cancers Program, Division Chief of Breast Medical Oncology and Professor of the Department of Medical Oncology and Therapeutics Research at City of Hope Comprehensive Cancer Center.

Watch hol+ by Dr. Taz MD on YouTube: https://www.youtube.com/@DrTazMD/podcastsThe incidence of breast cancer is rising and has now surpassed lung cancer as the leading cancer worldwide. This script features a comprehensive discussion between the host and Dr. Kristi Funk, a double board-certified breast cancer surgeon and lifestyle medicine doctor. The conversation covers the rising rates of breast cancer, key risk factors such as diet, exercise, and lifestyle choices, and the role of early detection and screening. Dr. Funk shares her personal experiences, insights on how younger and older women can reduce their risk, the impact of hormone replacement therapy, and the importance of lifestyle modifications. Additionally, advancements in breast cancer treatments, including immunotherapy and personalized medicine, are explored as hopeful developments in the fight against breast cancer.About Dr. Kristi FunkKristi Funk, M.D. is a double board-certified breast cancer surgeon, and lifestyle medicine doctor, bestselling author, and international speaker. She graduated from Stanford University in 1991, received her medical degree from UC Davis, completed her surgical residency in Seattle, and a breast cancer fellowship at Cedars-Sinai in Los Angeles. She excelled as a Director of the Cedars-Sinai Breast Center until 2009 when Dr. Funk co-founded the the Pink Lotus Breast Center in Los Angeles where she currently practices. She has helped thousands of women navigate breast issues, including celebrities like Angelina Jolie and Sheryl Crow. Dr. Funk's nutritional science expertise sparked twin passions: the online women's social network, Pink Lotus Power Up, and her annual in-person or virtual Cancer-Kicking! Summits. She is the go-to breast expert for Good Morning America and Dr. Phil's Merit Street Media; she was a co-host of The Doctors tv show, and has repeatedly appeared on Today, Rachael Ray, The Dr. Oz Show, CNN, The View, and more. She resides in Los Angeles, CA, with her husband and triplet sons.Stay ConnectedSubscribe to the audio podcast: https://holplus.transistor.fm/subscribeSubscribe to the video podcast: https://www.youtube.com/@DrTazMD/podcastsFollow Dr. Taz on Instagram: https://www.instagram.com/drtazmd/https://www.instagram.com/liveholplus/Join the conversation on X: https://x.com/@drtazmdTikTok: https://www.tiktok.com/@drtazmdFacebook: https://www.facebook.com/drtazmd/Connect with Dr. Kristi Funk:https://www.instagram.com/drkristifunkhttps://pinklotus.com/Host & Production TeamHost: Dr. Taz; Produced by Rainbow Creative (Executive Producer: Matthew Jones; Lead Producer: Lauren Feighan; Editors: Jeremiah Schultz and Patrick Edwards)Don't forget to like, subscribe, and hit the notification bell to stay updated on future episodes of hol+Time Stamps02:53 Current Trends and Statistics in Breast Cancer06:27 The Role of Genetics and Lifestyle in Breast Cancer09:33 Diet, Exercise, and Environmental Factors35:06 The Impact of Emotional Health on Breast Cancer41:22 Breast Cancer Screening for Young Women47:47 The Debate on Mammograms and Ultrasounds50:39 Understanding DCIS: Overdiagnosis and Overtreatment58:41 Hormone Replacement Therapy and Breast Cancer01:13:41 Future of Breast Cancer Care and Treatment

Join us for an in-depth update on recent clinical trial data on all advanced and metastatic breast cancer (BC) subtypes. Credit available for this activity expires: 06/18/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002644?ecd=bdc_podcast_libsyn_mscpedu

Breast cancer affects 12% of women in the U.S., and while genetics play a role, we can't forget about environmental and emotional factors. As guest Dr. Laura James says, “stress causes toxicity, period!” In this episode, Dr. James, integrative oncologist, shares the herbal strategies and emotional support tools she's seen make the biggest difference for women going through treatment. If you or someone you love is facing this battle, save and share this meaningful conversation. Show notes ⬇️ Show notes:  Recommendations Turkey tail Reishi Mushroom Green Tea Extract Acupuncture (helpful for nausea) Want more of The Ancient Health Podcast? Subscribe to the YouTube channel. Follow Dr. Chris Motley Instagram Follow Dr. Laura James! IG: https://www.instagram.com/doctorlaurand/ laurajamesnd.com (Sign up for her newsletter and check out her program) For her supplement line: bestforbreast.com Links:  *  If you're looking for a safe, easy way to improve your heart health, check out zona.com and use code DRMOTLEY for $100 off the Zona Plus device! * Do you have a ton more in-depth questions for Doctor Motley? Are you looking for more valuable resources on infections, the gut and your other pressing health topics? Join his membership for courses full of his expertise and clinical wisdom, plus bring all your questions to his weekly lives! Try it FREE for 15 days. Join here.

PJ speaks to Professor Janice Walsh, a leading oncologist on the latest break though in breast cancer care Hosted on Acast. See acast.com/privacy for more information.

Welcome to the Komen Health Equity Revolution podcast series. Each month, we invite in patients, community organizations, health care providers, researchers and policy advocates to discuss strategies and solutions that drive the health equity revolution forward for multiple populations experiencing breast health inequities. In honor of Black History Month, this Komen Health Equity Revolution episode of the Real Pink podcast takes a deep dive into the unique challenges and disparities Black women face in breast cancer care. Joining me is Komen Scientific Advisory Board member Dr. Lisa Newman, a trailblazing breast surgical oncologist and researcher. In this episode, we'll explore the lack of representation of Black bodies in the medical space and its impact on care and treatment. We'll also discuss culturally responsive care, the transformative role of diverse health care providers, and ways to advocate for yourself as a patient. Let's dive into this important conversation.

In this episode of Our Womanity Dr. Rachel Pope sits down with Dr. Lily Gutnik, a breast surgeon and global health advocate dedicated to advancing equitable healthcare for women.Dr. Gutnik's journey is deeply rooted in her experience as a first-generation immigrant. After her parents fled religious persecution in the former USSR, she grew up in the United States, where she developed a profound appreciation for education and hard work. Her global perspective—shaped by extensive travel, multilingual abilities, and cross-cultural training—has reinforced her commitment to diversity, equity, and inclusion in healthcare.A firm believer in innovative, cross-disciplinary collaborations, Dr. Gutnik focuses on implementing high-quality, cost-effective breast cancer care, particularly for vulnerable women. She champions a convergence science approach to address the complex root causes of health disparities, using implementation science to develop interventions that drive health equity.For Dr. Gutnik, becoming a breast surgeon is more than a profession—it is a mission to empower women through health. Tune in as she shares her insights on building sustainable healthcare solutions, tackling systemic inequities, and the future of breast cancer care.Featured in this episode: Stigma around breast cancer and mistrust in the African and African American community Discovering Hands Initiative empowering blind women Uninsured and underinsured patients still face barriers to care Advancing breast cancer treatment in the US – But at what cost? Tanzania leading the charge in education, awareness, and stigma reduction Tuskegee Syphilis StudyFollow us on social media: Instagram: @drrpope TikTok: @vulvadoctor Twitter: @drrpope LinkedInWant more from Our Womanity?If you enjoyed this episode of Our Womanity, please subscribe, rate, and leave a review. Your feedback helps us continue to bring you engaging and empowering content.

Watch hol+ by Dr. Taz MD on YouTube: https://www.youtube.com/@DrTazMD/podcastsThe incidence of breast cancer is rising and has now surpassed lung cancer as the leading cancer worldwide. This script features a comprehensive discussion between the host and Dr. Kristi Funk, a double board-certified breast cancer surgeon and lifestyle medicine doctor. The conversation covers the rising rates of breast cancer, key risk factors such as diet, exercise, and lifestyle choices, and the role of early detection and screening. Dr. Funk shares her personal experiences, insights on how younger and older women can reduce their risk, the impact of hormone replacement therapy, and the importance of lifestyle modifications. Additionally, advancements in breast cancer treatments, including immunotherapy and personalized medicine, are explored as hopeful developments in the fight against breast cancer.About Dr. Kristi FunkKristi Funk, M.D. is a double board-certified breast cancer surgeon, and lifestyle medicine doctor, bestselling author, and international speaker. She graduated from Stanford University in 1991, received her medical degree from UC Davis, completed her surgical residency in Seattle, and a breast cancer fellowship at Cedars-Sinai in Los Angeles. She excelled as a Director of the Cedars-Sinai Breast Center until 2009 when Dr. Funk co-founded the the Pink Lotus Breast Center in Los Angeles where she currently practices. She has helped thousands of women navigate breast issues, including celebrities like Angelina Jolie and Sheryl Crow. Dr. Funk's nutritional science expertise sparked twin passions: the online women's social network, Pink Lotus Power Up, and her annual in-person or virtual Cancer-Kicking! Summits. She is the go-to breast expert for Good Morning America and Dr. Phil's Merit Street Media; she was a co-host of The Doctors tv show, and has repeatedly appeared on Today, Rachael Ray, The Dr. Oz Show, CNN, The View, and more. She resides in Los Angeles, CA, with her husband and triplet sons.Thank you to our sponsorBiOptimizers:  bioptimizers.com/holplus04:36 Current Trends and Statistics in Breast Cancer08:10 The Role of Genetics and Lifestyle in Breast Cancer11:16 Diet, Exercise, and Environmental Factors36:49 The Impact of Emotional Health on Breast Cancer43:05 Breast Cancer Screening for Young Women49:30 The Debate on Mammograms and Ultrasounds52:22 Understanding DCIS: Overdiagnosis and Overtreatment1:00:24 Hormone Replacement Therapy and Breast Cancer01:15:24 Future of Breast Cancer Care and TreatmentStay ConnectedSubscribe to the audio podcast: https://holplus.transistor.fm/subscribeSubscribe to the video podcast: https://www.youtube.com/@DrTazMD/podcastsFollow Dr. Taz on Instagram: https://www.instagram.com/drtazmd/https://www.instagram.com/liveholplus/Join the conversation on X: https://x.com/@drtazmdTikTok: https://www.tiktok.com/@drtazmdFacebook: https://www.facebook.com/drtazmd/Connect with Dr. Kristi Funk:https://www.instagram.com/drkristifunkhttps://pinklotus.com/Host & Production TeamHost: Dr. Taz; Produced by Rainbow Creative (Executive Producer: Matthew Jones; Lead Producer: Lauren Feighan; Editors: Jeremiah Schultz and Patrick Edwards)Don't forget to like, subscribe, and hit the notification bell to stay updated on future episodes of hol+

In this enlightening episode of The Patient From Hell podcast, Dr. Doug Blayney and host Samira Daswani dive deep into the key insights from the 2024 San Antonio Breast Cancer Symposium (SABCS). They explore four critical areas of breast cancer care: CDK4/6 inhibitors, antibody-drug conjugates (ADCs), de-escalation strategies for ductal carcinoma in situ (DCIS), and the emerging role of artificial intelligence in cancer diagnostics. Throughout the conversation, a central theme emerges: the increasing ability to personalize cancer treatment, considering individual patient characteristics, biological markers, treatment options, and personal goals for quality and quantity of life. Key Highlights: 1. Biomarkers are becoming increasingly sophisticated, allowing for more precise and personalized treatment approaches across different breast cancer subtypes. 2. Patient choice and individual considerations are paramount, with treatment decisions now focusing on balancing potential survival benefits against quality of life impacts. 3. Emerging technologies like antibody-drug conjugates and artificial intelligence are revolutionizing breast cancer care by offering more nuanced, targeted diagnostic and treatment options. About our guest: Dr. Doug Blayney is an oncology physician who specializes in breast cancer and the Chief Medical Officer of Manta Cares. His research focuses on quality improvement in cancer care systems, new drug development, and patient experience improvement. At the American Society of Clinical Oncology (ASCO), he was founding Editor-in-Chief of its flagship practice journal, and as President, started the ASCO Quality Symposium and began planning for ASCO's CancerLinq. He was a founding member of the National Comprehensive Cancer Network (NCCN) Growth Factor Guideline panel, and is a past member of the U.S. Food and Drug Administration's Oncology Drugs Advisory Committee and the NCCN Board of Directors.  Key Moments: At 38 minutes: "There's a company now that has a gene expression panel that may predict, and it looks like it does predict, whether radiation treatment after standard treatment for DCIS is beneficial. So if this predicted biomarker of benefit for radiation pans out, and I think it probably will, that means that we can deescalate or personalize whether radiation treatment and its side effects are likely to be beneficial to that patient." At 45 minutes: "Quality of life, can that be answered by a nine question questionnaire? Well, maybe. If you can't get out of bed, your quality of life is because something hurts or if your arm doesn't work because they're so swollen, that's one extreme... What about 15 years playing that duet? What about three? It's those kind of subtleties that we need to take into account." At 49 minutes:"AI can interpret mammograms. The images from a mammogram 20 years ago, there were four, top, bottom, side, side, and maybe another oblique. And now there's 60 images from a mammogram. So that means that a radiologist, a human radiologist, whether it's next door or around the world, somebody needs to look at those. AI can help." Disclaimer: All content and information provided in connection with Manta Cares is solely intended for informational and educational purposes only.  This content and information is not intended to be a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

Love the episode? Send us a text!In this episode of Breast Cancer Conversations, I had the pleasure of speaking with Stephanie S. Abbott, a remarkable individual who has navigated the complex worlds of both healthcare administration and cancer survivorship. Stephanie brings a unique perspective, having served in multiple leadership roles in healthcare, including Chief Experience Officer for Adventist Health and Division Vice President of Patient Experience for HCA.Stephanie shared her personal journey, from her diagnosis on November 12, 2021, to her experiences as a patient undergoing treatment. She highlighted the emotional and operational challenges she faced, offering invaluable insights into the friction points within the healthcare system. Stephanie's story underscores the importance of human connection and effective communication between patients and healthcare providers.Stephanie is also the author of the book Buried or Planted: 100+ Expert Insights from a Healthcare Executive's Journey as a Cancer Patient on Amazon below: https://www.amazon.com/Buried-Planted-Insights-Healthcare-Executives/dp/B0D4Q9QM78SURVIVINGBREASTCANCER.ORGAttend a free virtual SurvivingBreastCancer.org event:https://www.survivingbreastcancer.org/eventsFollow us on InstagramSurvivingBreastCancer.org: https://www.survivingbreastcancer.org/Breast Cancer Conversations: https://www.instagram.com/breastcancerconversations/About SurvivingBreastCancer.org: SurvivingBreastCancer.org, Inc. (SBC) is a federally recognized 501(c)(3) non-profit virtual platform headquartered in Boston with a national and global reach. Through education, community, and resources, SurvivingBreastCancer.org supports women and men going through breast cancer. We provide a sanctuary of strength, compassion, and empowerment, where those diagnosed with cancer unite to share their stories, learn invaluable coping strategies to manage wellness and mental health, and find solace in the unbreakable bond that fuels hope, resilience, and the courage to conquer adversity.https://www.survivingbreastcancer.org/takeahikeSupport the show

In honor of Breast Cancer Awareness month – 25 weeks post surgery and outrageously grateful to be cancer free – Amanda revisits an episode from the messy middle of her breast cancer diagnosis. In this raw conversation, she talks candidly through her fears while trying to figure out what really matters for her health and life. This is a powerful conversation to share with any breast cancer survivor anyone in the messy middle of battling it now.  To listen to the first part of this conversation with Amanda, go to: Episode 309 Amanda's Diagnosis & What's Next (Pt. 1). And for more episodes on Breast Cancer Awareness, please also check out:  Episode 316 Amanda Returns Post Surgery: Here's What She Wants You To Know Episode 317 What Amanda's Learned About Life, Love & Community (Post Surgery Pt 2)  Episode 320 Early Detection, Mammograms & Breast Cancer Care with Dr. Rachel Brem Episode 321 Expert Advice on Genetic Testing, Cancer Prevention & Care Disparities with Dr. Rachel Brem To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

In this episode of Superwoman Wellness, we tackle the profound issue of breast cancer with the remarkable Dr. Jenn Simmons, author of the book The Smart Woman's Guide to Breast Cancer, a leading breast surgeon and integrative oncologist. Dr. Jenn was Philadelphia's first fellowship-trained breast surgeon, spending 17 years as the city's top expert. Her own health journey led her to discover the power of functional medicine, inspiring her to leave traditional practice in 2019 and found Real Health MD. Dr. Jenn is now pioneering new technologies and holistic approaches to help women truly heal along their breast cancer journeys.Join us as Dr. Jenn shares her unique insights on breast cancer prevention, diagnosis, and treatment. Dr. Jenn is currently opening PerfeQTion Imaging centers across the country featuring QT Imaging, an innovative technology that uses sound waves to create a 3D reconstruction of the breast without pain, compression, or radiation. —and discover the critical role of functional medicine in treating and preventing breast cancer.Today on Superwoman Wellness:Dr. Jen's transition from traditional breast surgeon to integrative oncologist.The impact of functional medicine in transforming breast cancer care.Debunking common myths about breast cancer diagnosis and treatment.The revolutionary QT imaging technology for safer breast cancer screening.The critical importance of addressing toxins, stress, and lifestyle in breast cancer prevention.Why DCIS (Ductal Carcinoma In Situ) is not breast cancer and how it should be treated.How hormone replacement therapy can play a role in post-cancer recovery.Empowering women to make informed decisions about their breast health.This show is supported by:EastWest - Use code SWW30 to get 30% off at theeastwestway.com.Follow Dr. Jenn Simmons: Website: Real Health MD Social Media: @drjennsimmons Book: The Smart Woman's Guide to Breast Cancer available on Amazon. Podcast: Keeping Abreast with Dr. JennQT Imaging: PerfeQTion ImagingFollow Dr. Taz:YouTube: @DrTazMDInstagram: @drtazmdWebsite: doctortaz.comCheck out "The Hormone Shift" book at prh.comthehormoneshiftThis Show is produced by ▶︎GOSTEK.media

321. Expert Advice on Genetic Testing, Cancer Prevention & Care Disparities with Dr. Rachel Brem Dr. Rachel Brem is back to discuss genetic testing for breast cancer risk, systemic issues within the medical establishment, guidance for those with dense breasts, and practical advice on MRI and mammograms. Plus, we'll hear some of the heartfelt and inspiring messages you've left us since you learned of Amanda's diagnosis.  Discover:  -The shocking statistic about who is most susceptible to breast cancer; -Why every doctor has a bias and what to do about it; -The truth about “overdiagnosis”; and  -How to get genetic testing and what to do with the information you receive. On Dr. Rachel Brem: Dr. Rachel Brem is the author of No Longer Radical: Understanding Mastectomies and Choosing the Breast Cancer Care That's Right For You. Dr. Brem is an internationally known breast cancer expert who has been instrumental in developing and implementing new technologies to improve breast cancer detection. She is Professor and Director of Breast Imaging and Intervention at George Washington University, Vice Chairman of the Department of Radiology, and Chief Medical Advisor and Cofounder of the Brem Foundation. She is a Fellow of the American College of Radiology and the Society of Breast Imaging. Find our first episode with Dr. Brem here: 320. Early Detection, Mammograms & Breast Cancer Care with Dr. Rachel Brem To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

320. Early Detection, Mammograms & Breast Cancer Care with Dr. Rachel Brem Amanda shares an update on her recovery from breast cancer. Then, renowned breast cancer expert, Dr. Rachel Brem, joins the conversation to discuss the critical importance of early detection, breast density's impact on mammography, and when we need additional screenings.  Discover:  -The differing guidance on screenings and the truth about how often you should actually get screened for cancer; -Advice on what to say to your doctors to make sure that you get the screening you need and so that they can be covered under insurance; and -How to learn how dense your breasts are and what to do with that information.  On Dr. Rachel Brem: Dr. Rachel Brem is the author of No Longer Radical: Understanding Mastectomies and Choosing the Breast Cancer Care That's Right For You. Dr. Brem is an internationally known breast cancer expert who has been instrumental in developing and implementing new technologies to improve breast cancer detection. She is Professor and Director of Breast Imaging and Intervention at George Washington University, Vice Chairman of the Department of Radiology, and Chief Medical Advisor and Cofounder of the Brem Foundation. She is a Fellow of the American College of Radiology and the Society of Breast Imaging. Find more resources at The Brem Foundation Website: https://www.bremfoundation.org/  Check out Dr. Brem's Book, No Longer Radical: https://www.nolongerradical.com/ To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices